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1. Introduction 
The gold standard for evaluating pathologies of the large bowel, including screening for 
colorectal cancer, is optical colonoscopy, in spite of the fact that it is an invasive procedure 
and needs to be performed by an expert endoscopist. Colon capsule endoscopy is a new 
minimally invasive diagnostic procedure for exploring the large bowel. It does not require 
sedation, air insufflation or intubation. The few available clinical studies on this device have 
shown levels of safety, feasibility and performance as being comparable to those of optical 
colonoscopy. Colon capsule endoscopy is also well tolerated by the patients and it is 
currently considered an   acceptable alternative for cases of "incomplete" colonoscopy, as 
well as for subjects unwilling to undergo the optical colonoscopy procedure, or those with 
contraindications for an invasive procedure. This raises the question of whether colon 
capsule endoscopy can eventually replace optical colonoscopy as a diagnostic tool. On the 
one hand, its has the advantage of being highly likely to increase compliance for undergoing 
colorectal cancer screening among asymptomatic individuals. On the other hand, its 
preparation protocols are even more stringent than those for optical colonoscopy, and the 
detection of suspected or obvious pathology mandates that the individuals return to 
undergo optical colonoscopy. Moreover, since the capsule does not expulse by 10 hours (the 
maximum battery life) for various reasons in approximately 8% of the cases, the colon will 
not have been examined in its entirety. We believe that colon capsule endoscopy will 
eventually replace optical colonoscopy as a first-line procedure when solutions are found for 
those drawbacks 
2. Cololrectal cancer screening  
Colorectal cancer (CRC) is the second leading cause of cancer death, and accounts for 
approximately 9% of cancer deaths overall (Jemel, 2010)  Optical colonoscopy  (OC) is a 
procedure in widespread use and the one advocated as the procedure of choice for 
screening and prevention of CRC by many authors (Brenner et al' ,2010;Baxter et al' 2009)  In 
spite of its being the gold standard for CRC screening, OC has several limitations: only an 
experienced endoscopist is qualified to perform it (Rex,2002), limited endoscopy resources 
may limit its application for large, population-based screening programs, it must examine 
the entire colon, including cecum intubation (Shah,2007;Rex,2006), and it is an invasive 
procedure that requires sedation, with discomfort and embarrassment to the patient, leading 
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to low compliance rates (Bujanda,2007). Moreover, previous studies (Barclay,2006; 
Bensen,1999)) have documented variations in OC procedures, adenoma detection rates and 
colonoscope withdrawal times among examiners (Rex 1997; Barclay,2006). The overall 
reported miss rate for neoplastic polyps ranges from 8-24% (Bensen,1999;Rex 1997,). Several 
Canadian case control and cohort studies found that colonoscopy reduced the incidence and 
mortality of distal but not proximal CRC (Singh,2010a; Singh,2010b;Lakoff,2008).  
There are other drawbacks associated with OC. The need for sedation requires that the 
examinee have an escort home, it increases the costs, and it may induce complications, such 
as cardiac arrhythmias, hypotension, oxygen desaturation, and others OC also carries a the 
risk of perforation of about one in 1,000 cases and death in about one in 5,000 cases 
(Orsoni,1997;Weitzmann,2001). It may fail to demonstrate the entire colon in 10–15% of 
cases, and may miss up to 10–20% of polyps <1 cm in size (Shah, 2007; Rex, 2006; Bresselr, 
2004; Picakardt, 2004; Heresbach , 2008;). Finally, the miss rate of OC for large adenomas 
and malignancy has been shown to be about 12% and 5%, respectively (17-19). All these 
negative factors can impact on the compliance in asymptomatic subjects who consider OC 
for colorectal screening.  
3. Colon Capsule Endoscopy (CCE) 
CCE represents a new diagnostic technology for colonic exploration. Its objectives are to 
pass through the entire colon while transmitting images similar to OC, as well as to identify 
colonic pathologies. The ultimate goals are for it to complement or eventually replace the 
diagnostic OC for CRC screening and for diagnosing obscure gastrointestinal (GI) bleeding, 
the cause of positive fecal occult blood tests, iron deficiency anemia, and suspected 
inflammatory bowel disease (i.e., determining the disease extent or even monitoring 
mucosal healing in established cases). It is also intended to provide information in cases of 
incomplete colonoscopy and be applicable when OC poses a significant risk or is 
contraindicated, such as for patients with co-morbidities which preclude sedation or bowel 
preparation.  
3.1 Technical description and operational data 
The CCE system (Given Imaging Ltd., Yoqneam, Israel) consists of a battery-powered video 
capsule with two imagers, one at each end of the capsule. The capsule transmits signals 
through an antenna-lead array to a small data recorder worn around the waist of the 
examinee. The data can then be uploaded to a personal computer-based workstation and 
viewed with the RAPID® software.  
The first generation Pillcam Colon capsule is 11 X 31 mm in size and has two wide-angle 
(156 degrees) imagers, one at each end. The frame acquisition is set at a constant rate of 4 per 
second (i.e., 2 frames per second per camera). The capsule's activity starts automatically 
upon removal from its packaging. Three minutes after being swallowed, the capsule enters 
into a "sleep" mode for one hour and 45 minutes, after which it becomes activated and starts 
recording. 
The second generation Pillcam Colon 2 (Figure 1) is 11.6 X 31.5 mm in size and has two 
wide-angle (176 degrees) imagers, one at each end, yielding an almost 360º coverage. It is 
equipped with an adaptive frame rate (AFR) feature of 4-35 frames that vary depending on 
its rate of movement. The Pillcam Colon 2 captures images at an initial constant rate of 14 
frames per second until the small bowel is reached.  
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Fig. 1. PillCam®Colon Capsule 2nd generation 
When it identifies the small bowel, the AFR feature is activated and the image acquisition 
function switches to the variable rate mode. The adaptive frame rate feature maximizes 
tissue coverage, optimizes the length of recording, conserves battery power and provides a 
smooth video replay. The main differences between the two models are summarized in 
Table 1 
 
Pillcam Colon 2nd 
generation 
Pillcam Colon 1st 
generation 
Parameter 
Bidirectional One-way Communication 
Adaptive (4-35) Constant (4 per second) Frame rate (per second) 
Simple Multi-step Two click process Polyp size estimation 
176º 156º Field of view  
Automatic  Light control 
Advanced 1st generation Optics  
Real-time image rate  
control 
Guidance  
(medical staff, patient) 
Storage of capsule video Data recorder 
Table 1. The differences between the two colon capsule    
The data recorder within the capsule of a CCE system has several important features: 
bidirectional communication ability that helps control the frame rate,. a notification feature 
which alerts and helps guide the patient through the process, and 3. a real-time viewing 
capability by means of a liquid crystal diode display (Eliakim ,2006). 
3.2 Clinical data 
Despite the great enthusiasm generated by this new technique, there are only a few clinical 
studies in the literature (Eliakim,2006,2009,2010,;Schoof,2006;Van Gossum,2009;, Sacher-
Huvelin2010; Rokkas,2010; Sieg ,2010 Pilz,2010, Spade 2010,2011a,2011b;Fireman,2007), and 
the reported results in the initial ones on the first CCE generation (Eliakim,2006, 
Schoof,2006; Van Gossum,2009) showed low sensitivity, specificity and predictive values. 
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The first two pilot studies (Eliakim,2006;Schoof,2006) demonstrated the feasibility and safety 
of CCE, however, a multicenter study that evaluated the detection of polyps and 
malignancy reported that the sensitivity of the technique was limited (Van 
Gossum,2009).The published data on the sensitivity and specificity are summarized in 
Tables 2-6.  
 
Specificity (%) Sensitivity (%) 
No. 
Patients 
CCE Reference 
71 58 545 
1st 
generation 
Sacher-Huvelin et al. 
54 79 59 
1st 
generation 
Pilz, et al 
78 72 328 
1st 
generation 
Van Gossum et al. 
89 73 626 
1st 
generation 
Rokkas et al. 
75 71 837 
1st 
generation 
Spada et al.(2010) 
CCE, colon capsule endoscopy 
*Meta-analysis  
Table 2. Sensitivity and specificity for any type and size of polyp 
These reported results were analyzed and grouped in different subgroups, according to the 
size and type of polyp. For "any" polyp, the sensitivity and specificity ranged between 58-
79% and 54-89%, respectively (Table 2). For polyps ≥6 mm in size, the sensitivity and 
specificity were 39-69% and 73-88%, respectively, for the first generation CCE (Eliakim,2006 
,2010,Schoof,2006;Van Gossum,2009;, Sacher-Huvelin2010; Rokkas, 2010; Pilz,2010, Spade 
2010,2011), and 89% and 76%, respectively, for the second generation CCE (27) (Table 3). 
 
Specificity (%) Sensitivity (%) No. Patients CCE Reference 
88 39 545 1st generation Sacher-Huvelin et al. 
84 64 328 1st generation Van Gossum et al. 
76 50 59 1st generation Pilz et al. 
83 58 91 1st generation Eliakim et al(2009) 
73 60 41 1st generation Schoofs et al.22 
86*  69*  626 1st generation *Rokkas et al.25 
82 68 837 1st generation *Spada et al(2011) 
87 63 40 1st generation Spada et al(2011) 
76 89 104 2nd generation Eliakim et al(2009) 
CCE, colon capsule endoscopy *Significant polyp: >6 mm or ≥3 polyps of any size. 
Table 3. Sensitivity and specificity for polyps ≥6 mm  
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The sensitivity and specificity of CCE for advanced adenoma ranged between 72-73% and 
57-79%, respectively (Table 4), and the sensitivity and specificity for malignant lesions 
ranged between 60-76% and 74-100%, respectively (Table 5). 
 
Reference CCE No. Patients 
 
Sensitivity (%) Specificity (%) 
Sacher-Huvelin et al. 1st generation 545 72 57 
Van Gossum et al. 1st generation 328 *73  79* 
CCE, colon capsule endoscopy*Advanced adenomas (≥6 mm) 
Table 4. Sensitivity and specificity for advanced adenoma 
 
Reference CCE 
No. Patients  Sensitivity 
(%) 
Specificity (%) 
Sacher-Huvelin et al. 
1st 
generation 
545 
60 100 
Van Gossum et al. 
1st 
generation 
328 
74 74 
Spada et al. (2010) 
1st 
generation 
837 
76  
CCE, colon capsule endoscopy*Meta-analysis 
Table 5. Sensitivity and specificity for colorectal cancer 
OC considered the gold standard, in this context it is important to understand that there 
are various limitations, for example the fact that the findings that were demonstrated on 
CCE and not on OC were considered as false positive, a fact which could account for an 
artificial low specificity. The latter is due to the possibility that at least in some cases the 
capsule endoscopy identified lesions that colonoscopy missed. Indeed, in a large multi-
center French study (Sachaer- Huvelin,2010) that offered a repeat colonoscopy for these 
patients the differences in accuracy between CCE and optical colonoscopy were 
minimized.  So  that the CCE specificity might practically represent the supremacy of the 
CCE over OC.  Another cofactor is the fact that in most studies the majority of subjects 
included were known to have an established or suspected colonic disease (past history of 
adenomas or colon cancer, abnormal imaging findings etc.) or a high clinical suspicion of 
colonic disease (rectal bleeding, hematochezia, melena, positive occult blood, change in 
bowel habits, diarrhea or constipation). An example of such study is the one reported by 
by Van Gossum et al (Van Gossum,2009). In other studies, the total number of subjects 
that were recruited was limited and the percentage of subjects that were referred for 
screening was small. For example the article by Eliakim et al. (Eliakim 2009) recruited 
about 104 patients, of whom 32% were referred for screening.  Pilz et al. (Pilz,2010),a total 
of 59 subjects were recruited of whom  only 41% were referred for screening. A study 
which examined the issue of screening and surveillance in a more targeted fashion 
(Sacher-Huvelin,2010) included 545 subjects of whom about 30% were at an average risk 
(screening) and 70% were at an increased risk (surveillance) failed to demonstrate non 
inferiority in relation to colonoscopy. Sensitivity and specificity in this sample was about 
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39% and 88% respectively for polyps of 6 mm or larger. The researchers concluded that 
the CCE cannot yet replace the optical colonoscopy as a first choice for screening and 
surveillance purposes. 
It should be noted that the reported sensitivity of CT colonography for detecting polyps≥6 mm 
as reported in an article by Johnson et al. (Johnson,2008) is about 78%, a figure which is higher 
than most of those reported for sensitivity for the first generation CCE, however, for the 
second generation CCE.  Eliakim et al. (Eliakim,2009) and Spada et. al. (Spada, 2011) reported  
for sensitivity 89% and 84% respectively(Table 6). 
 
 1st generation 2nd generation# 
Study Van Gossum Eliakim(2009) Spada(2011) 
No site 8 European 5 Israeli 8 European 
No. Patients 320 98 109 
Polyp≥6 mm 
Prevalence 27%(87) 24%(35) 41%(45) 
Sensitivity 64% 89% 84% 
Specificity 84% 76% 64%/92%* 
Polyp ≥10 mm 
Prevalence 16%(50) 14%(20) 29%(32) 
Sensitivity 60% 88% 88% 
Specificity 98% 89% 95% 
*After unblinding  
Table 6. The first vs. 2nd  generation Colon Capsule  
Thus, the sensitivity, specificity and accuracy are insufficient for recommending CCE for 
wide clinical use,— at least for the first generation CCE — as concluded by Van Gossum et 
al (Van Gossum,2009). The technological improvements of the second generation CCE show 
promising and encouraging results, as was shown by a recent publications (Eliakim,2009, 
Spada,2010) (Table 6). More in-depth studies on screening average-risk populations as well 
as surveillance of at-risk populations are warranted, with an eye towards extending the 
indications for CCE. 
4. Preparation protocol 
The colon must be clean of any residual material in order to perform CCE, unlike the case of OC 
where it is possible to suction it. A typical preparation protocol, as described in an article by 
Eliakim et al. (Eliakim,2009) (Table 7), includes a diet based on clear liquids to be followed the 
day before the examination, a split dose of 4 liters of polyethylene glycol (PEG) solution (2 liters 
during the evening before the examination and 2 liters in the morning of the examination), oral 
sodium phosphate boosters and a bisacodyl suppository. The aim of the sodium phosphate and 
bisacodyl additions is to maintain a clean colon and expedite the passage of the capsule down 
the bowel and its excretion within 10 hours following capsule ingestion. 
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DAY BEFORE EXAMINATION  
All day Clear liquid diet 
Evening 2 liters polyethylene glycol 
EXAMINATION DAY  
07:00 2 liters polyethylene glycol 
10:00 Capsule ingestion 
1st booster (at detection of capsule in the 
small bowel) 
30 ml sodium phosphate and 1 liter water 
2nd booster (3 hours after 1st booster) 15 ml sodium phosphate and 0.5 liter water 
Suppository (2 hours after 2nd booster) 10 mg bisacodyl 
Table 7. Typical preparation protocol 
Similar protocols have been described in various studies (Table 8). Attempts to replace the 
booster of sodium phosphate with PEG yielded inferior results (Pilz ,2010). 
 
Clear 
liquid diet 
Low 
Fiber diet 
Bisacodyl 
suppository
Prokinetic 
NaP 
booster
PEG Reference 
Yes Yes Yes Tegaserod 1-2 3 Eliakim et al. 
Yes No Yes Domperidone 2 4 Schoofs et al 
Yes No Yes Domperidone 2 4 
Van Gossum 
 et al 
Yes Yes Yes Metoclopramide2 4 
Eliakim  
et al.(2009) 
PEG, polyethylene glycol; NaP, sodium phosphate 
Table 8. Colonic preparation  
4.1 Preparation quality 
Various studies have addressed the issue of grading the quality of bowel preparation. Colon 
cleanliness is usually categorized into excellent, good, fair, or poor. For ease of reporting and 
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for statistical analyses, most studies use the combinations of good-excellent and poor-fair 
(Table 9). Other studies have reported the quality of preparation as clean, moderate, or poor 
(Eliakim,2009). In addition to cleansing, bowel preparation for CCE also aims to facilitate the 
progress of the capsule through the digestive system as well as to keep certain amounts of 
clear liquids within the colonic lumen in order to allow visualization of the colonic mucosa. 
The latter is also known as the "submarine view", which substitutes for the insufflation and 
flushing used in OC.  
 
Reference 
Good-Excellent 
(%) 
Fair-Poor 
(%) 
Sacher-Huvelin et al. 52 48 
Schoofs et al 88 12 
Eliakim et al(2006) 84.4 15.6 
Van Gossum et al.  72 28 
Spada et al (2010) 70 30 
Spada et al(.2011) 42.5 57.5 
Eliakim et al.( 2009) 78 22 
*Meta-analysis 
Table 9. Colon cleanliness 
As with all other imaging methods of exploring the colon, the quality of bowel preparation 
significantly affects the quality of a CCE study's interpretation and results. Unlike OC, the 
capsule requires a clean colon for a relatively long period of time and, as noted earlier, there is 
no means of remove content. Several studies have addressed the influence of bowel 
preparation on the CCE sensitivity.  One large European multicenter study (Van Gossum 
,2009), which recruited about 328 subjects, found a significant effect of bowel preparation on 
the CCE sensitivity, with a negligible impact on its specificity. Those authors noted that the 
sensitivity and specificity for polyps ≥6 mm in patients with excellent or good bowel 
preparation were 75% and 84%, respectively, compared with 42% and 84% fair or poor 
preparation. For lesions consistent with advanced adenoma, excellent or good bowel 
preparation yielded a sensitivity and specificity of 88% and 78% respectively, while fair to 
poor bowel preparation had a sensitivity and specificity of 44% and 81%, respectively. 
Therefore, it emerges that one of the limitations of CCE is the need for aggressive preparation 
protocol, which has a negative effect on patients' compliance (Van Gossum ,2009). 
5. Capsule egestion  
Capsule egestion while the battery is still operating is an important issue in terms of achieving 
a complete study of the bowel (Table 10). The location of the CCE within the colon upon "wake 
up" was also an important factor for the first generation of the Pillcam colon capsule. 
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At 10 hours 
(%) 
At 8 hours 
(%) 
At 6 hours 
(%) 
Reference 
91   Sacher-Huvelin et al. 
92.8  69.1 Van Gossum et al 
64   Pilz et al 
 81 65 Eliakim et al.(2009) 
Table 10. Capsule egestion 
The absence of information from any location of the CCE distal to the cecum has been 
associated with loss of crucial information and considered as being an incomplete result. 
Although this phenomenon has been reported in only a minority of subjects, it still 
constituted a major pitfall of the procedure. In this context, Van Gossum et al (Van 
Gossum,2009). reported that after one hour and 45 minutes (consistent with the CCE 
"sleeping mode" phase), the capsule was found at or distal to the cecum in 312 of 320 
patients (97.5%), within the cecum in five (1.5%), in the ascending colon in two (0.6 %), and 
the sigmoid colon in one (0.3%). The Pillcam Colon 2 technology has overcome this obstacle 
by its unique AFR feature. 
6. Adverse events 
Minimal side effects were reported in various studies on CCE. Most of them were mild to 
moderate in severity (e.g., nausea, abdominal pain, etc.), and they were mainly related to the 
bowel preparation. In their meta-analysis on CCE, Spada et al.(Spada 2011) reported that the 
rate of these side effects was ranged between 2.6 to 5.6%. 
6.1 Patient satisfaction 
Only limited information is available on patient satisfaction with CCE. When tested on a 
visual analogue scale, the results were only slightly better for CCE compared to OC (Sacher-
Huvelin,2010). Of 53 subjects who underwent colonoscopy in a CCE study published by Pilz 
et al. (Pilz, 2010), 40% preferred the CCE, 38% preferred OC, and 23% had no preference. 
6.2 CCE advantages and drawbacks 
Advantages of this method are not needing sedation, intubation or air insufflation, thus 
obviating the risks of complications associated with an invasive test, especially in cases 
where the capsule yields negative results and colonoscopy is not required. The examination 
itself is free of pain and the examinee can carry on with regular activities. When CCE locates 
abnormal findings and the patient is referred to OC, the endoscopist knows in advance the 
size and location of the lesion. There is certain logistical limitation: in the case of abnormal 
findings on CCE, the patient can be spared undergoing a second cleansing preparation only 
if the CCE video is reviewed promptly and OC can be scheduled at short notice.  
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In terms of disadvantages, OC permits lens clearing by applying water jet, suctioning of 
colonic contents and irrigation capability, thus allowing visualization of the colonic mucosa 
and the interpretation of images obtained during colonoscopy at a lower level of cleanliness 
than that required by CCE. Because CCE lacks these features, a more intensive bowel 
preparation is required. Another reason for a more stringent bowel preparation is the need 
to facilitate capsule passage and allow a certain amount of clear liquids within the colonic 
lumen in order to enable visualization of the mucosa (made possible with the aid of air 
insufflation in OC). This aggressive bowel preparation might well be responsible for low 
compliance rates for undergoing CCE. 
Another disadvantage of the CCE is the lack of therapeutic capabilities, even though several 
studies have shown that polyps <6 mm in size do not need to be removed due to the 
relatively low risk of malignancy (Johnson,2008;Pickhardt,2003). Furthermore, virtual 
colonoscopy does not capture images of polyps <6 mm. Limited battery power which 
sometimes precludes the ability to complete a full study is another drawback. Although the 
second generation CCE can save battery power through its AFR feature and do so without 
losing information (compared with the "sleeping mode" of the first generation CCE), this 
still poses a limitation, especially in cases where the capsule has been delayed in the 
stomach or small intestine. 
The last issue in this respect is the high cost of the CCE system, which is a major factor in 
currently limiting its extensive clinical use. 
6.3 Limitations of the research methodology 
The element of reviewers' experience in interpreting CCE images is a significant factor. 
Gastroenterologists have accumulated considerable experience in OC, while experience with 
CCE is far more limited. Eliakim et al (Eliakim,2006) reported that the specificity values of 
CCE ranged from 83% to 100%, depending on the reviewers' experience. Notably, most 
studies on CCE recruited subjects who were not representative of a typical screening 
population, so that their data could not be used to draw conclusions about the use of CCE in 
the setting of routine screening.  
7. Conclusions 
Based on currently available data, CCE can not be recommended as a substitute for OC, but 
it can serve as a supplementary test in cases of incomplete colonoscopy, when there are 
contraindications to colonoscopy, or for patients who are unwilling to undergo colonoscopy. 
The improvements afforded by the second-generation capsule are promising and 
encouraging, and such enhanced technology will lead to more widespread use that will 
reduce the cost of testing.  Expectations in the future of CCE include self-propelled capsules, 
a more efficient/external energy source, a side imager for extending the field of view and 
minimizing blind areas, and a mouth to anus capsule with the ability for complete 
evaluation of all parts of the digestive system (e.g., in cases of obscure GI bleeding). 
Shortening the period of capsule reading and initial analysis of the images by a 
computerized "reviewer", and expanding the capsule to other fields, such as motility 
assessment, will add to the attractiveness of CCE in the clinical setting. 
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As result of progress, endoscopy has became more complex, using more sophisticated devices and has
claimed a special form. In this moment, the gastroenterologist performing endoscopy has to be an expert in
macroscopic view of the lesions in the gut, with good skills for using standard endoscopes, with good
experience in ultrasound (for performing endoscopic ultrasound), with pathology experience for confocal
examination. It is compulsory to get experience and to have patience and attention for the follow-up of
thousands of images transmitted during capsule endoscopy or to have knowledge in physics necessary for
autofluorescence imaging endoscopy. Therefore, the idea of an endoscopist has changed. Examinations
mentioned need a special formation, a superior level of instruction, accessible to those who have already
gained enough experience in basic diagnostic endoscopy. This is the reason for what these new issues of
endoscopy are presented in this book of New techniques in Gastrointestinal Endoscopy.
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